Concepedia

Aaron P. Jansen

AP

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

1999

Affiliations

National Cancer Institute(Current)

Frederick National Laboratory for Cancer Research

University of Wisconsin–Madison

Center for Cancer Research

Science Applications International Corporation (United States)

Aaron P. Jansen is an author at National Cancer Institute specializing in oncology, molecular biology, and molecular oncology.

Publications per year

1999–2008

8

Publications

8

The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

Hsin‐Sheng Yang, Aaron P. Jansen, Anton A. Komar et al. · Molecular and Cellular Biology · 2002 · 489 citations · Full text

, , +17

Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis

Aaron P. Jansen, Corinne E. Camalier, Nancy H. Colburn · Cancer Research · 2005 · 213 citations · Full text

, , +17

Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

Giridhar Mudduluru, Fabian Medved, Rainer Grobholz et al. · Cancer · 2007 · 197 citations · Full text

, , +17

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation

Hsin‐Sheng Yang, Aaron P. Jansen, Rajalakshmi Nair et al. · Oncogene · 2001 · 186 citations

, , +10

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

Tobias Schmid, Aaron P. Jansen, Alyson R. Baker et al. · Cancer Research · 2008 · 154 citations

, , +17

1–5 of 8